Jan Moritz Middeke

机构：Fresenius (Germany), National Center for Tumor Diseases, Großmann Ingenieur Consult (Germany), University Hospital Carl Gustav Carus, Klinik und Poliklinik für Psychotherapie und Psychosomatik, Hochschule für Technik und Wirtschaft Dresden – University of Applied Sciences, Nationales Centrum für Tumorerkrankungen Dresden, Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden · ORCID：0000-0003-3250-293X

发表论文 243 篇 · 总被引 5346 次 · h-index 39

代表论文

Towards autonomous medical artificial intelligence agents (2026 · Nature · 被引 6)
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial (2025 · Blood · 被引 6)
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients (2025 · Leukemia · 被引 5)
Artificial intelligence-generated synthetic data for cancer research and clinical trials (2026 · Nature reviews. Cancer · 被引 4)
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia (2025 · npj Precision Oncology · 被引 4)
Artificial intelligence for risk assessment and outcome prediction in malignant haematology (2025 · British Journal of Haematology · 被引 2)